77 related articles for article (PubMed ID: 20567201)
1. Pigmented deposits on a Boston keratoprosthesis from topical ibopamine.
Kanoff JM; Colby K
Cornea; 2010 Sep; 29(9):1069-71. PubMed ID: 20567201
[TBL] [Abstract][Full Text] [Related]
2. Topical ibopamine in the treatment of chronic ocular hypotony attributable to vitreoretinal surgery, uveitis, or penetrating trauma.
Ugahary LC; Ganteris E; Veckeneer M; Cohen AC; Jansen J; Mulder PG; van Meurs JC
Am J Ophthalmol; 2006 Mar; 141(3):571-3. PubMed ID: 16490513
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of uveitis-associated refractory ocular hypotony with topical ibopamine].
Windisch BK; Iliev ME
Klin Monbl Augenheilkd; 2006 May; 223(5):422-4. PubMed ID: 16705521
[TBL] [Abstract][Full Text] [Related]
4. Topical ibopamine and corticosteroids in the treatment of post-surgery ocular hypotony.
Virno M; De Gregorio F; Pannarale L; Arrico L
Int Ophthalmol; 1996-1997; 20(1-3):147-50. PubMed ID: 9112179
[TBL] [Abstract][Full Text] [Related]
5. Ibopamine treatment in chronic hypotony secondary to long-lasting uveitis. A case report.
Pivetti-Pezzi P; Da Dalt S; La Cava M; Pinca M; De Gregorio F; Virno M
Eur J Ophthalmol; 2000; 10(4):332-4. PubMed ID: 11192843
[TBL] [Abstract][Full Text] [Related]
6. Six months treatment with ibopamine in patients with hypotony after vitreoretinal surgery for retinal detachment, uveitis or penetrating trauma.
Ganteris-Gerritsen E; Ugahary LC; Jansen J; Mulder PG; Cohen AF; van Meurs JC
Retina; 2012 Apr; 32(4):742-7. PubMed ID: 21909052
[TBL] [Abstract][Full Text] [Related]
7. Treatment of mild heart failure: the place of diuretics and ibopamine.
Van Veldhuisen DJ
Eur Heart J; 1997 May; 18(5):712-4. PubMed ID: 9152639
[No Abstract] [Full Text] [Related]
8. Increase in aqueous humor production following D1 receptors activation by means of ibopamine.
Virno M; Taverniti L; De Gregorio F; Sedran L; Longo F
Int Ophthalmol; 1996-1997; 20(1-3):141-6. PubMed ID: 9112178
[TBL] [Abstract][Full Text] [Related]
9. Rapid corneal adrenochrome deposition from topical ibopamine in the setting of infectious keratitis.
Bhosai SJ; Lin CC; Greene J; Bloomer MM; Jeng BH
Eye (Lond); 2013 Jan; 27(1):105-6. PubMed ID: 23079754
[No Abstract] [Full Text] [Related]
10. Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME II) Investigators.
Hampton JR; van Veldhuisen DJ; Kleber FX; Cowley AJ; Ardia A; Block P; Cortina A; Cserhalmi L; Follath F; Jensen G; Kayanakis J; Lie KI; Mancia G; Skene AM
Lancet; 1997 Apr; 349(9057):971-7. PubMed ID: 9100622
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, cross-over comparison of the effects of a loop diuretic and a dopamine receptor agonist as first line therapy in patients with mild congestive heart failure.
Andrews R; Charlesworth A; Evans A; Cowley AJ
Eur Heart J; 1997 May; 18(5):852-7. PubMed ID: 9152656
[TBL] [Abstract][Full Text] [Related]
12. Fungal colonization and infection in Boston keratoprosthesis.
Barnes SD; Dohlman CH; Durand ML
Cornea; 2007 Jan; 26(1):9-15. PubMed ID: 17198007
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the stability of Boston type I keratoprosthesis-donor cornea interface using anterior segment optical coherence tomography.
Garcia JP; Ritterband DC; Buxton DF; De la Cruz J
Cornea; 2010 Sep; 29(9):1031-5. PubMed ID: 20517152
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of ibopamine treatment in patients with advanced heart failure: purpose of a new therapeutic scheme with multiple daily administrations.
Dei Cas L; Metra M; Nodari S; Visioli O
J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S111-7. PubMed ID: 2483436
[TBL] [Abstract][Full Text] [Related]
15. Ibopamine provocative test and glaucoma: consideration of factors that may influence the examination.
Magacho L; Lima FE; Costa ML; Fayad FA; Guimarães NL; Avila MP
Curr Eye Res; 2004 Mar; 28(3):189-93. PubMed ID: 14977521
[TBL] [Abstract][Full Text] [Related]
16. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
Aldave AJ; Kamal KM; Vo RC; Yu F
Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
[TBL] [Abstract][Full Text] [Related]
17. Pupillographic evaluation of the mydriatic effect of ibopamine solution.
Gelmi C; Palazzuolo A; Lucchetti M; Trimarchi F
Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):346-51. PubMed ID: 2777423
[TBL] [Abstract][Full Text] [Related]
18. Boston type 1 keratoprosthesis: the university of california davis experience.
Bradley JC; Hernandez EG; Schwab IR; Mannis MJ
Cornea; 2009 Apr; 28(3):321-7. PubMed ID: 19387235
[TBL] [Abstract][Full Text] [Related]
19. The Boston keratoprosthesis in Stevens-Johnson syndrome.
Sayegh RR; Ang LP; Foster CS; Dohlman CH
Am J Ophthalmol; 2008 Mar; 145(3):438-44. PubMed ID: 18207122
[TBL] [Abstract][Full Text] [Related]
20. [Ibopamine: the message, the messenger and the need of pharmacoepidemiological research].
Stricker BH; Feenstra J; Ottervanger JP
Ned Tijdschr Geneeskd; 1996 Apr; 140(15):848-50. PubMed ID: 8668281
[No Abstract] [Full Text] [Related]
[Next] [New Search]
